Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease

John Ong^{1

2

3}, Mandour O Mandour¹, Michael Allison^{1

4}

Affiliations

¹ Cambridge Liver Unit, Department of Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
² School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
³ Depatment of Medicine, National University of Singapore, Singapore.
⁴ NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom.

Comment

John Ong et al. Am J Gastroenterol. 2023.

. 2023 Oct 1;118(10):1899.

doi: 10.14309/ajg.0000000000002274.

John Ong^{1

2

3}, Mandour O Mandour¹, Michael Allison^{1

4}

¹ Cambridge Liver Unit, Department of Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
² School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
³ Depatment of Medicine, National University of Singapore, Singapore.
⁴ NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom.

No abstract available

Comment on

Regression of Hepatic Fibrosis After Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
Jirapinyo P, Zucker SD, Thompson CC. Jirapinyo P, et al. Am J Gastroenterol. 2023 Jun 1;118(6):983-990. doi: 10.14309/ajg.0000000000002087. Epub 2022 Dec 23. Am J Gastroenterol. 2023. PMID: 36597405

1. Jirapinyo P, Zucker SD, Thompson CC. Regression of hepatic fibrosis after endoscopic gastric plication in nonalcoholic fatty liver disease. Am J Gastroenterol 2023;118(6):983–90.
1. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015;149(2):367–78.e5.
1. Astrup A, Rössner S, Van Gaal L, et al. Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study. Lancet 2009;374(9701):1606–16.
1. Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA 2022;327(2):138–50.
1. Sanyal AJ, Foucquier J, Younossi ZM, et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores. J Hep 2023;78(2):247–59.